Weight Loss and Prediabetes (Healthy Habits: Healthy Blood Sugar Study)
Protocol: STUDY00004427
Full Title
Glucose Variability During Weight Control Treatment in Adults with Prediabetes
This study enrolls adults at risk for Type 2 Diabetes who are interested in weight loss. The purpose of this study is to learn the impact of a behavioral weight-loss treatment.

As a participant you will receive free treatment and materials to help change eating and activity behaviors. The treatment program lasts for about 4 months and teaches a lifelong eating plan. During the study you will be asked to wear a continuous blood glucose monitor. Study takes place at UB's South Campus.

Technical Description

To determine how glucose variability is affected by the use of continuous glucose monitoring during the course of weight loss treatment. To determine if changes in glucose variability during the course of weight loss treatment are correlated with changes in weight and/or changes in hemoglobin A1c.
Compensation: Yes
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Adults ages 18+
Have prediabetes (Blood A1c at or near prediabetic range of 5.4%-6.7%).
Not diagnosed with Type 2 diabetes or substance abuse/dependence.
Age Group: Adults
Principal Investigator: LEONARD EPSTEIN
Mathew Biondolillo
Want to Learn More?
Enrollment Update

Due to COVID-19, new enrollment in research studies will be greatly limited. If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry. View the guidance for research participants for additional information.

Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.